BioCentury
ARTICLE | Clinical News

DTaP vaccine: Completed Phase III trial

August 1, 1994 7:00 AM UTC

North American Vaccine (NVX), Beltsville, Md. Product: DTaP vaccine Indication: Childhood immunization against whooping cough, diphtheria and tetanus Status: Completed Phase III trial for efficacy in...